#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinal dystrophy Cervix carcinoma Phaeochromocytoma Cholestatic pruritus Epidermolysis bullosa Complex regional pain syndrome Type IIa hyperlipidaemia Neovascular age-related macular degeneration Pancreatic carcinoma Metastatic gastric cancer Vaginal cancer B-cell lymphoma refractory Malignant glioma Hodgkin's disease Arrhythmogenic right ventricular dysplasia More trials…

    Learn about Rare Diseases

    Undifferentiated sarcoma – Trials in Disease Nephrotic syndrome – Trials in Disease Hairy cell leukaemia recurrent – Trials in Disease Prader-Willi syndrome – Trials in Disease Epidermolysis bullosa – Basic Information Systemic sclerosis pulmonary – Diagnostics Netherton’s syndrome – Diagnostics Soft tissue sarcoma – Diagnostics Synovial sarcoma metastatic – Trials in Disease Factor VIII deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PEGVISOMANT XYLOMETAZOLINE HYDROCHLORIDE Vemircopan Cholic Acid Cannabis Sativa Flower Tafasitamab Osimertinib 2-DEOXY-D-GLUCOSE Guanfacine Mb-Cart20.1 MAPLIRPACEPT Indacaterol Maleate D5-Ethyl-Beta-D-Glucuronide VTX-002 Specific Nucleic Acid Sna-Xfsb Enasidenib Mesilate Roxithromycin Cariprazine Dapagliflozin Propanediol Esmolol Hydrochloride More therapies…

    Learn about Your Condition

    Latent tuberculosis Liver transplant rejection Dry mouth Respiratory distress Osteomyelitis acute Phaeochromocytoma Weaning failure Barrett's oesophagus T-cell lymphoma Ventricular extrasystoles Acute lymphocytic leukaemia Arginase deficiency Gastrooesophageal cancer Oesophagectomy Myofascial pain syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Liver transplant

  • Study of Human Albumin Treatment to Prevent Kidney Dysfunction in Adult Patients After Liver Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Liver transplant
    Investigated Drugs:
    • Human Albumin Solution
    France

  • Safety Study of Regulatory T Cells (Treg02) and Tacrolimus Discontinuation in Adult Liver Transplant Recipients

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Liver transplant
    Investigated Drugs:
    • Treg02
    • Paracetamol
    • Tacrolimus
    Germany

  • Study on the Safety of Atezolizumab and Bevacizumab for Liver Transplant Patients with Advanced Liver Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Liver transplant
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Bevacizumab
    • Atezolizumab
    France

  • Study on the Effects of Tacrolimus and Mycophenolate Mofetil in Patients After Liver Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Liver transplant
    Investigated Drugs:
    • Mycophenolate Mofetil
    • Tacrolimus
    France

  • Study on the Effect of Arginine-Vasopressin and Noradrenaline Tartrate on Acute Kidney Injury in Liver Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute kidney injury
    • Liver transplant
    Investigated Drugs:
    • Argipressin
    • Noradrenaline Tartrate
    France

  • Study on Organ Preservation in Kidney, Liver, and Pancreas Transplants Using Custodiol-N Solution Compared to a Drug Combination for Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Liver transplant
    • Renal transplant
    Investigated Drugs:
    • Aspartic Acid
    • Calcium
    • Chloride Ion
    Austria
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!